Dainippon Screen (DINRF) Lowered to “Sell” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research downgraded shares of Dainippon Screen (OTCMKTS:DINRF) from a hold rating to a sell rating in a research note issued to investors on Friday morning.

According to Zacks, “SCREEN Holdings Co Ltd. manufactures and sells semiconductors. Its operating segments includes SE, GP and FT. SE segment develops and manufactures semiconductor production equipment and conducts sales and maintenance services. GP segment, graphic arts equipment and PCB related equipment are developed, manufactured, sold and maintained. FT segment develops, manufactures and markets FPD production equipment as well as maintenance services. SCREEN Holdings Co Ltd. is based in Kyoto, Japan. “

DINRF stock traded down $1.85 during midday trading on Friday, reaching $86.00. The company had a trading volume of 100 shares. Dainippon Screen has a 1 year low of $86.00 and a 1 year high of $87.85.

Dainippon Screen Company Profile

SCREEN Holdings Co, Ltd., through its subsidiaries, develops, manufactures, sells, and maintains semiconductor production equipment in China. The company operates through three segments: Semiconductor Solutions, Graphic and Precision Solutions, and Finetech Solutions. It offers single wafer cleaners, wet stations, scrubbers, and laser annealers.

Featured Article: What are earnings reports?

Get a free copy of the Zacks research report on Dainippon Screen (DINRF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Dainippon Screen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dainippon Screen and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Middleby  Downgraded to “Hold” at Zacks Investment Research
Middleby Downgraded to “Hold” at Zacks Investment Research
Regeneron Pharmaceuticals  Given Buy Rating at Argus
Regeneron Pharmaceuticals Given Buy Rating at Argus
Nordex  Given a €10.00 Price Target at Commerzbank
Nordex Given a €10.00 Price Target at Commerzbank
Uniper  Given a €24.00 Price Target at Royal Bank of Canada
Uniper Given a €24.00 Price Target at Royal Bank of Canada
Koninklijke Philips  Given a €37.90 Price Target at JPMorgan Chase & Co.
Koninklijke Philips Given a €37.90 Price Target at JPMorgan Chase & Co.
Rhoen Klinikum  Given a €24.00 Price Target at Independent Research
Rhoen Klinikum Given a €24.00 Price Target at Independent Research


Leave a Reply

© 2006-2018 Ticker Report